Literature DB >> 10698693

Neutral sphingomyelinase activity dependent on Mg2+ and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium falciparum.

K Hanada1, T Mitamura, M Fukasawa, P A Magistrado, T Horii, M Nishijima.   

Abstract

Sphingolipid metabolism and metabolites are important in various cellular events in eukaryotes. However, little is known about their function in plasmodial parasites. Here we demonstrate that neutral sphingomyelinase (SMase) involved in the sphingomyelin (SM) catabolism is retained by the intraerythrocytic parasite Plasmodium falciparum. When assayed in a neutral pH buffer supplemented with Mg(2+) and phosphatidylserine, an activity for the release of the phosphocholine group from SM was detected in parasite-infected, but not in uninfected, erythrocyte ghosts. The SMase activity in the parasite-infected erythrocyte ghosts was enhanced markedly by anionic phospholipids including unsaturated but not saturated phosphatidylserine. Mn(2+) could not substitute for Mg(2+) to activate SMase in parasite-infected erythrocyte ghosts, whereas both Mn(2+) and Mg(2+) activated mammalian neutral SMase. The specific activity level of SMase was higher in isolated parasites than in infected erythrocyte ghosts; further fractionation of lysates of the isolated parasites showed that the activity was bound largely to the membrane fraction of the parasites. The plasmodial SMase seemed not to hydrolyse phosphatidylcholine or phosphatidylinositol. The plasmodial SMase, but not SM synthase, was sensitive to scyphostatin, an inhibitor of mammalian neutral SMase, indicating that the plasmodial activities for SM hydrolysis and SM synthesis are mediated by different catalysts. Our finding that the malaria parasites possess SMase activity might explain why the parasites seem to have an SM synthase activity but no activity to synthesize ceramide de novo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698693      PMCID: PMC1220899     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Nucleotide sequence: the beta-hemolysin gene of Staphylococcus aureus.

Authors:  S J Projan; J Kornblum; B Kreiswirth; S L Moghazeh; W Eisner; R P Novick
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

2.  Gametocyte formation by the progeny of single Plasmodium falciparum schizonts.

Authors:  J Inselburg
Journal:  J Parasitol       Date:  1983-06       Impact factor: 1.276

3.  The subcellular localization of neutral sphingomyelinase in rat liver.

Authors:  K Y Hostetler; P J Yazaki
Journal:  J Lipid Res       Date:  1979-05       Impact factor: 5.922

4.  Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene.

Authors:  S L Schissel; E H Schuchman; K J Williams; I Tabas
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

5.  Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.

Authors:  F Nara; M Tanaka; T Hosoya; K Suzuki-Konagai; T Ogita
Journal:  J Antibiot (Tokyo)       Date:  1999-06       Impact factor: 2.649

6.  Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus.

Authors:  A Yamada; N Tsukagoshi; S Udaka; T Sasaki; S Makino; S Nakamura; C Little; M Tomita; H Ikezawa
Journal:  Eur J Biochem       Date:  1988-08-01

7.  Functional reconstitution of sphingomyelin synthase in Chinese hamster ovary cell membranes.

Authors:  K Hanada; M Horii; Y Akamatsu
Journal:  Biochim Biophys Acta       Date:  1991-11-05

Review 8.  Lipids and the malarial parasite.

Authors:  G G Holz
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

9.  The origin of parasitophorous vacuole membrane lipids in malaria-infected erythrocytes.

Authors:  G E Ward; L H Miller; J A Dvorak
Journal:  J Cell Sci       Date:  1993-09       Impact factor: 5.285

10.  Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells.

Authors:  P Grellier; D Rigomier; V Clavey; J C Fruchart; J Schrevel
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more
  18 in total

Review 1.  Channel-induced apoptosis of infected host cells-the case of malaria.

Authors:  Florian Lang; Philipp A Lang; Karl S Lang; Verena Brand; Valerie Tanneur; Christophe Duranton; Thomas Wieder; Stephan M Huber
Journal:  Pflugers Arch       Date:  2004-03-20       Impact factor: 3.657

2.  Acyclic immucillin phosphonates: second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.

Authors:  Keith Z Hazleton; Meng-Chiao Ho; Maria B Cassera; Keith Clinch; Douglas R Crump; Irving Rosario; Emilio F Merino; Steve C Almo; Peter C Tyler; Vern L Schramm
Journal:  Chem Biol       Date:  2012-06-22

3.  Profiling the Essential Nature of Lipid Metabolism in Asexual Blood and Gametocyte Stages of Plasmodium falciparum.

Authors:  Sonia Gulati; Eric H Ekland; Kelly V Ruggles; Robin B Chan; Bamini Jayabalasingham; Bowen Zhou; Pierre-Yves Mantel; Marcus C S Lee; Natasha Spottiswoode; Olivia Coburn-Flynn; Daisy Hjelmqvist; Tilla S Worgall; Matthias Marti; Gilbert Di Paolo; David A Fidock
Journal:  Cell Host Microbe       Date:  2015-09-09       Impact factor: 21.023

Review 4.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 5.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

6.  PG12, a phospholipid analog with potent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine cytidylyltransferase activity.

Authors:  Patricia González-Bulnes; April M Bobenchik; Yoann Augagneur; Rachel Cerdan; Henri J Vial; Amadeu Llebaria; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2011-06-25       Impact factor: 5.157

7.  Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.

Authors:  Ravi S Kasinathan; Michael Föller; Saisudha Koka; Stephan M Huber; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-19       Impact factor: 3.000

8.  Sphingolipid analogues inhibit development of malaria parasites.

Authors:  Esmeralda V S Meyer; Jason J Holt; Kathryn R Girard; Mark T Ballie; Anatoliy S Bushnev; Stacey Lapp; David S Menaldino; Richard F Arrendale; G Prabhakar Reddy; Taylor J Evers; Randy B Howard; Deborah G Culver; Dennis C Liotta; Mary R Galinski; Michael G Natchus
Journal:  ACS Med Chem Lett       Date:  2011-12-06       Impact factor: 4.345

9.  Expression, immunolocalization, and serological reactivity of a novel sphingomyelin phosphodiesterase-like protein, an excretory/secretory antigen from Clonorchis sinensis.

Authors:  Yanwei Huang; Youwei Zheng; Yuzhe Li; Mei Yang; Ting Li; Suxiang Zeng; Xinbing Yu; Huaiqiu Huang; Xuchu Hu
Journal:  Parasitol Res       Date:  2013-04-09       Impact factor: 2.289

Review 10.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.